CURL
发表于 2025-3-26 23:02:12
http://reply.papertrans.cn/79/7801/780078/780078_31.png
Notorious
发表于 2025-3-27 02:00:02
http://reply.papertrans.cn/79/7801/780078/780078_32.png
ARC
发表于 2025-3-27 06:07:50
http://reply.papertrans.cn/79/7801/780078/780078_33.png
fatty-acids
发表于 2025-3-27 12:43:32
http://reply.papertrans.cn/79/7801/780078/780078_34.png
SCORE
发表于 2025-3-27 15:33:42
http://reply.papertrans.cn/79/7801/780078/780078_35.png
增长
发表于 2025-3-27 20:17:07
Martina Klockes and biotechnology will soon bear fruit. In this sense it seems as though the “knowledge gap hypothesis” which attributed the decline in drug innovation in the 1960s and 1970s to a lack of fundamental knowledge may prove to be historically correct. The idea that complicated diseases can only be und
PANT
发表于 2025-3-28 00:42:46
Siegfried Reiths and biotechnology will soon bear fruit. In this sense it seems as though the “knowledge gap hypothesis” which attributed the decline in drug innovation in the 1960s and 1970s to a lack of fundamental knowledge may prove to be historically correct. The idea that complicated diseases can only be und
trigger
发表于 2025-3-28 04:03:11
Johan Vesterageriseases such as SLE. Rituximab also has a longer established role in the treatment of B-cell lymphoproliferative disorders and rheumatoid arthritis. In this chapter we review the available data on the safety aspects of B-cell targeted therapies. A common adverse event with this family of agents is i
antidote
发表于 2025-3-28 07:16:22
http://reply.papertrans.cn/79/7801/780078/780078_39.png
strdulate
发表于 2025-3-28 11:34:57
http://reply.papertrans.cn/79/7801/780078/780078_40.png